Tag: Liver Disease: Misc.
Some Cirrhosis Patients Given Opioid Rx at Outpatient Visits
Authors say primary care providers in particular need more education on the potential harms of opioids in patients with liver disease
Higher Serum Iron May Up Liver Cancer Risk in NAFLD Patients
Increased risk for hepatocellular carcinoma also seen with higher transferrin saturation levels in patients with nonalcoholic fatty liver disease
Fibrosis Stages F3, F4 in NAFLD Linked to Higher Mortality Risk
Incidence of all-cause mortality increased with increasing fibrosis stage; increase also seen in liver-related complications
Lanifibranor Reduces Disease Activity in Nonalcoholic Steatohepatitis
In phase 2b trial, more patients with active NASH had reduction in disease activity score with lanifibranor versus placebo
Survival Rates Lower for Black Liver Transplant Recipients
For Blacks versus Whites, differences in post-LT mortality narrowed between 2002 and 2009, increased between 2014 and 2018
Donor HLA Evolutionary Divergence May Predict Liver Transplant Rejection
Class I HED of the donor is associated with higher risk for acute and chronic rejection of the liver transplant
Toxic Dust Exposure Tied to Liver Disease in WTC Responders
Earlier arrival time at World Trade Center associated with decreased liver attenuation on computed tomography
Maternal Obesity May Up Risk for Future Liver Disease in Offspring
Maternal obesity in early pregnancy linked to increased risk for nonalcoholic fatty liver disease in the child by age 25 years
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Hepatitis B Virus Monitoring Needed After Liver Transplantation
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection